From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days？
Once a household name known for its ‘slimming tea,’ the company is looking for a new formula in dietary drugs after years of losses and asset sales Key Takeaways: Besunyen…
Falling global birth rates drag Jinxin into the red
The fertility services provider lost up to 1 billion yuan in the first half of this year after taking large impairment charges on its U.S. and Laotian operations Key Takeaways:…
Will new investor Goldstream bring its Midas touch to Saint Bella?
The investment company disclosed its purchase of 0.3% of the maternity and baby care company’s stock on the open market Key Takeaways: Goldstream Investment acquired 1.83 million Saint Bella shares,…
Ab&B fortifies for battle over China’s vaccine market
With proceeds from a Hong Kong IPO, the loss-making biotech is bidding for a piece of China’s fiercely competitive market for flu and human rabies vaccines Key Takeaways: The company’s…
Rising profit at WuXi Biologics underscores drug sector rebound
The provider of pharmaceutical services has joined other flagship companies in the WuXi group in projecting stronger first-half earnings after a couple of lean years Key Takeaways: WuXi Biologics expects…
Hengrui Pharma targets obesity drug launch after test success
The Chinese drug company is looking to break into the big league for weight-loss treatments after its injection demonstrated sustained weight loss in Phase Three trials Key Takeaways: Participants receiving…
PomDoc offers up well-conceived but overvalued digital healthcare IPO
The online health services provider aims to raise up to $30 million through a Nasdaq listing, even as its liabilities far outweigh its assets Key Takeaways: PomDoc aims to raise…
Recent Articles
RELATED ARTICLES
-
Its Hong Kong listing advancing, will investors drink up Bama Tea shares?
- Forget the pearls and cheese, Chagee says, offering up simpler milk teas for U.S. investors
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
Yan Palace flies back to profit growth as revenue sags
1497.HK
-
Feihe’s sliding profits point to China dairy market past its sell-by date
6186.HK
-
NEWS WRAP: Green Tea Group slumps on Hong Kong trading debut
6831.HK
-
BRIEF: Intercont shares fall in first two trading days after U.S. IPO
NCT.US
